Check out the latest Women's Health news, including interviews and press releases here.
New BD survey finds nearly half of women unaware of STI treatment options
Featured in FiercePharma, new Harris Poll findings reveal women want to be more informed by their HCPs when it comes to STIs, testing and treatment options.
New Harris Poll Finds Women Want More Education on Sexually Transmitted Infections Testing and Treatment
BD released findings from a survey conducted online by The Harris Poll, reporting that women feel less knowledgeable about testing and treatment options for sexually transmitted infections (STIs) compared to other vaginal diseases and infections.
Business Insider: Getting the HPV vaccine and regular testing can help protect you from high-risk HPV strains that cause cancer
Dr. Jeff Andrews, VP Medical Affairs, Integrated Diagnostic Solutions, shares statistics with Business Insider about knowledge gaps in cervical cancer causes and tests.
Press Release: BD Onclarity™ HPV Assay Receives FDA Approval for Use with Both BD SurePath™ Liquid-based Pap Test and Hologic ThinPrep® Pap Test
The BD Onclarity™ HPV Assay has received FDA Approval for use with both BD SurePath™ Liquid-based Pap Test and Hologic ThinPrep® Pap Test, which expands access to the HPV test that more precisely identifies patients’ risk for cervical cancer.
Contemporary OB/GYN: Harris Poll study from BD reveals knowledge gap and inequity in HPV screening and cervical cancer
In Contemporary OB/GYN, Dr. Jeff Andrews, VP Medical Affairs, shares findings from a Harris Poll noting gaps in women's knowledge about HPV and cervical cancer.
POLITICO: Women don’t know when to get screened for cervical cancer, survey finds
Dr. Jeff Andrews, VP Medical Affairs, Integrated Diagnostic Solutions, shares insights in POLITICO from a survey conducted by The Harris Poll noting significant gaps in women’s understanding about the causes and prevention of cervical cancer.
POV: The U.S. healthcare system is failing Black and Latina women
In this Fast Company op-ed, Brooke Story, BD Integrated Diagnostic Solutions president, challenges and encourages the advocacy for strengthening health care systems, improving testing infrastructure and delivering the highest quality care, regardless of race, geographic location, or socioeconomic status.
Press Release: New Harris Poll Reveals Significant Gaps in Women's Knowledge About Cervical Cancer
BD released findings from a survey conducted by The Harris Poll that indicate a significant gap in women’s knowledge about the primary causes of cervical cancer as well as the most effective means of prevention.
Healthcare Purchasing News: Women’s health at all ages & stages
Simply put, cervical cancer is avoidable. The latest issue of Healthcare Purchasing News highlights how the BD Onclarity™ HPV Assay is shaping the future of women’s health and improving standards of care as the only FDA-approved HPV test that individually identifies high-risk HPV 31.
Clinical Lab Products: The Future of Cervical Cancer Screening is Here
Associate Director of Medical Affairs Molly Broache notes that in today’s world where patients are catching up on missed screenings, adding pressure on already-pressured labs, it’s that much more important to take advantage of instruments and assays that do more and do better.
Stay up-to-date with the latest news from BD Women's Health!